ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 622696 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 622696; 2) Community: the network communities that were significantly associated with the response to NSC 622696; 3) Molecule: the relationships between components within communities and NSC 622696; 4) MDR: the compounds that were significantly associated with the NSC 622696.

NSC Compound Enrichment Correlation
NSC 733397 1-alpha-methyl-8-methoxy-5-bromo-6,7,-methylenedioxy-1-(6,7, -dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline 0.0247979034812109 0.42667252
NSC 736591 Null 0.0247979034812109 0.4749184
NSC 763730 Null 0.0247979034812109 0.41332395
NSC 102225 Null 0.024797903481211 0.32572005
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.024797903481211 0.2388984
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.024797903481211 0.13049753
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.024797903481211 0.52646591
NSC 270057 Hydroxypristimerin 0.024797903481211 0.46463491
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.024797903481211 0.43938196
NSC 330507 Tanespimycin 0.024797903481211 0.22176985
Total:107  Current:68    [First] [Prev] [Next] [Last]